Loading...

Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison

The incidences of infusion site adverse events in chemotherapy regimens, including anthracyclines with either fosaprepitant or aprepitant as the anti-emetic, were not highlighted in the randomized trial comparing aprepitant and fosaprepitant. The present retrospective analysis was performed in breas...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: TSUDA, TAKASHI, KYOMORI, CHISATO, MIZUKAMI, TAKURO, TANIYAMA, TOMOKO, IZAWA, NAOKI, HORIE, YOSHIKI, HIRAKAWA, MAMI, OGURA, TAKASHI, NAKAJIMA, TAKAKO EGUCHI, TSUGAWA, KOICHIRO, BOKU, NARIKAZU
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812534/
https://ncbi.nlm.nih.gov/pubmed/27073673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.769
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!